Agilent Technologies Share Holder Equity 2010-2025 | A
Agilent Technologies share holder equity from 2010 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
- Agilent Technologies share holder equity for the quarter ending January 31, 2025 was $6.027B, a 2.6% decline year-over-year.
- Agilent Technologies share holder equity for 2024 was $5.898B, a 0.91% increase from 2023.
- Agilent Technologies share holder equity for 2023 was $5.845B, a 10.18% increase from 2022.
- Agilent Technologies share holder equity for 2022 was $5.305B, a 1.56% decline from 2021.
| Agilent Technologies Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $5,898 |
| 2023 | $5,845 |
| 2022 | $5,305 |
| 2021 | $5,389 |
| 2020 | $4,873 |
| 2019 | $4,748 |
| 2018 | $4,571 |
| 2017 | $4,835 |
| 2016 | $4,246 |
| 2015 | $4,170 |
| 2014 | $5,304 |
| 2013 | $5,289 |
| 2012 | $5,185 |
| 2011 | $4,316 |
| 2010 | $3,236 |
| 2009 | $2,514 |
| Agilent Technologies Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-01-31 | $6,027 |
| 2024-10-31 | $5,898 |
| 2024-07-31 | $5,903 |
| 2024-04-30 | $6,214 |
| 2024-01-31 | $6,188 |
| 2023-10-31 | $5,845 |
| 2023-07-31 | $5,558 |
| 2023-04-30 | $5,781 |
| 2023-01-31 | $5,609 |
| 2022-10-31 | $5,305 |
| 2022-07-31 | $5,091 |
| 2022-04-30 | $5,122 |
| 2022-01-31 | $5,154 |
| 2021-10-31 | $5,389 |
| 2021-07-31 | $4,946 |
| 2021-04-30 | $4,810 |
| 2021-01-31 | $4,804 |
| 2020-10-31 | $4,873 |
| 2020-07-31 | $4,981 |
| 2020-04-30 | $4,768 |
| 2020-01-31 | $4,848 |
| 2019-10-31 | $4,748 |
| 2019-07-31 | $4,747 |
| 2019-04-30 | $5,125 |
| 2019-01-31 | $5,036 |
| 2018-10-31 | $4,571 |
| 2018-07-31 | $4,568 |
| 2018-04-30 | $4,617 |
| 2018-01-31 | $4,526 |
| 2017-10-31 | $4,835 |
| 2017-07-31 | $4,611 |
| 2017-04-30 | $4,375 |
| 2017-01-31 | $4,300 |
| 2016-10-31 | $4,246 |
| 2016-07-31 | $4,346 |
| 2016-04-30 | $4,165 |
| 2016-01-31 | $4,048 |
| 2015-10-31 | $4,170 |
| 2015-07-31 | $4,106 |
| 2015-04-30 | $4,161 |
| 2015-01-31 | $4,240 |
| 2014-10-31 | $5,304 |
| 2014-07-31 | $5,640 |
| 2014-04-30 | $5,629 |
| 2014-01-31 | $5,447 |
| 2013-10-31 | $5,289 |
| 2013-07-31 | $4,790 |
| 2013-04-30 | $5,308 |
| 2013-01-31 | $5,351 |
| 2012-10-31 | $5,185 |
| 2012-07-31 | $4,873 |
| 2012-04-30 | $4,725 |
| 2012-01-31 | $4,499 |
| 2011-10-31 | $4,316 |
| 2011-07-31 | $4,200 |
| 2011-04-30 | $3,961 |
| 2011-01-31 | $3,339 |
| 2010-10-31 | $3,236 |
| 2010-07-31 | $2,810 |
| 2010-04-30 | $2,632 |
| 2010-01-31 | $2,598 |
| 2009-10-31 | $2,514 |
| 2009-07-31 | $2,489 |
| 2009-04-30 | $2,419 |
| 2009-01-31 | $2,571 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $32.907B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $224.526B | 27.00 |
| Boston Scientific (BSX) | United States | $152.309B | 38.13 |
| Stryker (SYK) | United States | $147.916B | 30.93 |
| EssilorLuxottica (ESLOY) | France | $129.703B | 0.00 |
| Medtronic (MDT) | Ireland | $109.157B | 15.94 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.583B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.109B | 26.80 |
| ResMed (RMD) | United States | $36.312B | 27.27 |
| GE HealthCare Technologies (GEHC) | United States | $33.806B | 16.05 |
| Terumo (TRUMY) | Japan | $27.953B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.765B | 16.36 |
| Insulet (PODD) | United States | $22.130B | 86.87 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.288B | 12.39 |
| Baxter (BAX) | United States | $15.985B | 11.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.381B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.091B | 23.97 |
| Lantheus Holdings (LNTH) | United States | $5.462B | 13.78 |
| Prestige Consumer Healthcare (PBH) | United States | $4.298B | 19.20 |
| Perrigo (PRGO) | Ireland | $3.605B | 9.14 |
| ICU Medical (ICUI) | United States | $3.534B | 26.06 |
| Haemonetics (HAE) | United States | $3.473B | 15.13 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.154B | 26.21 |
| QuidelOrtho (QDEL) | United States | $2.401B | 16.52 |
| GN Store Nord (GNNDY) | Denmark | $2.164B | 17.92 |
| LeMaitre Vascular (LMAT) | United States | $1.882B | 42.06 |
| AtriCure (ATRC) | United States | $1.558B | 0.00 |
| Neogen (NEOG) | United States | $1.409B | 18.03 |
| AdaptHealth (AHCO) | United States | $1.217B | 12.36 |
| Kestra Medical Technologies (KMTS) | United States | $1.179B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.172B | 26.35 |
| BioLife Solutions (BLFS) | United States | $1.097B | 0.00 |
| InMode (INMD) | Israel | $1.038B | 9.50 |
| Phibro Animal Health (PAHC) | United States | $0.996B | 12.75 |
| Evolus (EOLS) | United States | $0.653B | 0.00 |
| CeriBell (CBLL) | United States | $0.600B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.577B | 0.00 |
| Owens & Minor (OMI) | United States | $0.559B | 4.63 |
| Valneva SE (VALN) | France | $0.534B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.524B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
| Surmodics (SRDX) | United States | $0.398B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.350B | 0.00 |
| SNDL (SNDL) | Canada | $0.347B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.333B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.312B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.309B | 11.36 |
| Aurora Cannabis (ACB) | Canada | $0.290B | 51.60 |
| Sanuwave Health (SNWV) | United States | $0.285B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.97 |
| Canopy Growth (CGC) | Canada | $0.267B | 0.00 |
| Omeros (OMER) | United States | $0.258B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.255B | 0.00 |
| Cerus (CERS) | United States | $0.250B | 0.00 |
| ZimVie (ZIMV) | United States | $0.248B | 11.28 |
| Biote (BTMD) | United States | $0.214B | 6.02 |
| OraSure Technologies (OSUR) | United States | $0.198B | 0.00 |
| High Tide (HITI) | Canada | $0.186B | 0.00 |
| Brainsway (BWAY) | Israel | $0.185B | 49.05 |
| Quanterix (QTRX) | United States | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 14.47 |
| Organigram Global (OGI) | Canada | $0.166B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.148B | 18.19 |
| Jin Medical (ZJYL) | China | $0.133B | 0.00 |
| Exagen (XGN) | United States | $0.120B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| Agape ATP (ATPC) | $0.101B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Fonar (FONR) | United States | $0.077B | 10.71 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.070B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| United Health Products (UEEC) | United States | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Safety Shot (SHOT) | United States | $0.034B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.020B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |